Nanobiosym
MA - CambridgeBiotechnology
Focus: Nanobiosym is a nanobiotech company founded in 2019 and headquartered in Cambridge, MA, focused on biotechnology applications of nanoscale biology. The company is actively hiring across 51 open positions, indicating growth-stage operations.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
34+17 this month
Growing — net +17 jobs in 30d
17 jobs added vs 0 removed. Steady team buildout.
Should You Work at Nanobiosym?
AI assessmentNanobiosym represents a high-risk, early-stage opportunity suited for risk-tolerant professionals seeking foundational roles in an emerging platform technology, but limited transparency demands due diligence on runway and strategic direction before committing.
Why Work Here
- Early-stage nanobiotech platform with active expansion (51 open roles) suggests growth trajectory and potential equity upside
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Nanobiosym
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.